Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients

Hypertension

Volumn 68, Issue 2, 2016, Pages 401-410

  Eirin, Alfonso ^a   Saad, Ahmed ^a   Tang, Hui ^a   Herrmann, Sandra M ^a   Woollard, John R ^a   Lerman, Amir ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

acute kidney injury; biomarkers; hypertension; mitochondria; oxygen

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE 3; KIDNEY INJURY MOLECULE 1; MITOCHONDRIAL DNA; NADH DEHYDROGENASE SUBUNIT 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; NADH DEHYDROGENASE SUBUNIT 1, HUMAN;

ADRENAL BLOOD FLOW; AGED; ARTICLE; BOLD SIGNAL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE DOSAGE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXIA; INTRARENAL HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGENATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; ACUTE KIDNEY FAILURE; BLOOD PRESSURE MEASUREMENT; HYPERTENSION; HYPERTENSION, RENOVASCULAR; KIDNEY; KIDNEY CIRCULATION; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; STATISTICS; URINE;

ACUTE KIDNEY INJURY; AGED; BIOMARKERS; BLOOD PRESSURE DETERMINATION; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; KIDNEY; LIPOCALIN-2; MALE; MIDDLE AGED; MITOCHONDRIA; NADH DEHYDROGENASE; RENAL CIRCULATION; STATISTICS AS TOPIC;

EID: 84975459284     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07849     Document Type: Article

References (30)

1. Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322. doi: 10.1161/CIR.0000000000000152.
2. Saran R, Li Y, Robinson B, et al. Us renal data system 2014 annual data report: Epidemiology of kidney disease in the united states. Am J Kidney Dis. 2015;66(1 suppl 1):Svii, S1-S305. doi: 10.1053/j.ajkd.2015.05.001.
3. Eirin A, Lerman A, Lerman LO. Mitochondria: a pathogenic paradigm in hypertensive renal disease. Hypertension. 2015;65:264-270. doi: 10.1161/HYPERTENSIONAHA.114.04598.
4. de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Inserra F. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1616-R1625. doi: 10.1152/ ajpregu.00615.2005.
5. Jin K, Vaziri ND. Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation. Clin Exp Nephrol. 2014;18:445-452. doi: 10.1007/ s10157-013-0851-3.
6. Zheleznova NN, Yang C, Ryan RP, Halligan BD, Liang M, Greene AS, Cowley AW Jr. Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat. Physiol Genomics. 2012;44:829-842. doi: 10.1152/ physiolgenomics.00060.2012.
7. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension. 2012;60:1242-1249. doi: 10.1161/HYPERTENSIONAHA.112.199919.
8. Eirin A, Ebrahimi B, Zhang X, Zhu XY, Woollard JR, He Q, Textor SC, Lerman A, Lerman LO. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease. Cardiovasc Res. 2014;103:461-472. doi: 10.1093/cvr/cvu157.
9. Fedorova LV, Sodhi K, Gatto-Weis C, Puri N, Hinds TD Jr, Shapiro JI, Malhotra D. Peroxisome proliferator-activated receptor α agonist, HPP593, prevents renal necrosis under chronic ischemia. PLoS One. 2013;8:e64436. doi: 10.1371/journal.pone.0064436.
10. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999;23:147. doi: 10.1038/13779.
11. Wenceslau CF, McCarthy CG, Szasz T, Spitler K, Goulopoulou S, Webb RC; Working Group on DAMPs in Cardiovascular Disease. Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J. 2014;35:1172-1177. doi: 10.1093/eurheartj/ehu047.
12. Whitaker RM, Stallons LJ, Kneff JE, Alge JL, Harmon JL, Rahn JJ, Arthur JM, Beeson CC, Chan SL, Schnellmann RG. Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury. Kidney Int. 2015;88:1336-1344. doi: 10.1038/ki.2015.240.
13. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension. 2010;55:961-966. doi: 10.1161/HYPERTENSIONAHA.109.145227.
14. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH, Jamerson KA, D'Agostino RB. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol. 2005;16:1295-1300. doi: 10.1097/01. RVI.0000176301.69756.28.
15. Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N, Crane PK, Pathak J, Chute CG, Bielinski SJ, Kullo IJ, Li R, Manolio TA, Chisholm RL, Denny JC. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med. 2011;3:79re1. doi: 10.1126/scitranslmed.3001807.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
17. Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard JR, Lerman A, Textor SC, Lerman LO. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Nephrol Dial Transplant. 2012;27:4153-4161. doi: 10.1093/ndt/gfs370.
18. Eirin A, Gloviczki ML, Tang H, Gössl M, Jordan KL, Woollard JR, Lerman A, Grande JP, Textor SC, Lerman LO. Inflammatory and injury signals released from the post-stenotic human kidney. Eur Heart J. 2013;34:540-548a. doi: 10.1093/eurheartj/ehs197.
19. Lerman LO, Taler SJ, Textor SC, Sheedy PF 2nd, Stanson AW, Romero JC. Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int. 1996;49:846-854.
20. Gloviczki ML, Lerman LO, Textor SC. Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension. Curr Hypertens Rep. 2011;13:370-377. doi: 10.1007/s11906-011-0218-7.
21. Saad A, Crane J, Glockner JF, Herrmann SM, Friedman H, Ebrahimi B, Lerman LO, Textor SC. Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology. 2013;268:770-778. doi: 10.1148/radiol.13122234.
22. Saad A, Herrmann SM, Crane J, Glockner JF, McKusick MA, Misra S, Eirin A, Ebrahimi B, Lerman LO, Textor SC. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv. 2013;6:428-435. doi: 10.1161/ CIRCINTERVENTIONS.113.000219.
23. Che R, Yuan Y, Huang S, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol. 2014;306:F367-F378. doi: 10.1152/ajprenal.00571.2013.
24. Abassi Z, Shalabi A, Sohotnik R, Nativ O, Awad H, Bishara B, Frajewicki V, Sukhotnik I, Abbasi A, Nativ O. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J Urol. 2013;189:1559-1566. doi: 10.1016/j.juro.2012.10.029.
25. Gloviczki ML, Glockner JF, Crane JA, McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension. 2011;58:1066-1072. doi: 10.1161/HYPERTENSIONAHA.111.171405.
26. Cooper CJ, Murphy TP, Cutlip DE, et al; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13-22. doi: 10.1056/NEJMoa1310753.
27. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol. 2004;75:995-1000. doi: 10.1189/jlb.0703328.
28. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-107. doi: 10.1038/ nature08780.
29. He J, Lu Y, Xia H, Liang Y, Wang X, Bao W, Yun S, Ye Y, Zheng C, Liu Z, Shi S. Circulating mitochondrial DAMPs are not effective inducers of proteinuria and kidney injury in rodents. PLoS One. 2015;10:e0124469. doi: 10.1371/journal.pone.0124469.
30. Zhang X, Li ZL, Eirin A, Ebrahimi B, Pawar AS, Zhu XY, Lerman A, Lerman LO. Cardiac metabolic alterations in hypertensive obese pigs. Hypertension. 2015;66:430-436. doi: 10.1161/HYPERTENSIONAHA.115.05478.